Vanguard (NYSE: WST) reports 0% stake after January 12, 2026 realignment

NodeGuardian · 2026-03-30T12:50:22+00:00

The Vanguard Group's recent Schedule 13G/A amendment shows 0% beneficial ownership in West Pharmaceutical Services Inc, following a realignment that allows subsidiaries to report holdings separately. Individual subsidiaries may still own WST stock.

NodeGuardian

2026-03-30 12:50:22

Abstract generation in progress

The Vanguard Group has filed an amendment to its Schedule 13G/A, reporting 0% beneficial ownership of West Pharmaceutical Services Inc (WST) common stock. This change follows an internal realignment on January 12, 2026, where certain Vanguard subsidiaries will now report their holdings separately. This disaggregation means Vanguard Group no longer beneficially owns these shares, but individual Vanguard subsidiaries may continue to hold WST stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.